ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

Drug-induced liver injury in pregnancy

(2020) Terence T. Lao   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

1089 CHARACTERIZATION OF STEROID THERAPY FOR DRUG-INDUCED LIVER INJURY

(2020) Jiayi Ma et al.   GASTROENTEROLOGY

Hepatotoxicity from Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation

(2020) Thoetchai (Bee) Peeraphatdit et al.   HEPATOLOGY

Incidence and Sequelae of Liver Injury among Children Treated for Solid Tumors

(2020) Vanessa Cardenas et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence

(2020) Raju K. Vaddepally et al.   Cancers

Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development

(2020) Arie Regev et al.   JOURNAL OF AUTOIMMUNITY

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update

(2020) Jessica P. Hwang et al.   JOURNAL OF CLINICAL ONCOLOGY

Profile of herbal and dietary supplements induced liver injury in Latin America: A systematic review of published reports

(2020) Genario Santos et al.   PHYTOTHERAPY RESEARCH

Drug induced liver injury: an update

(2020) Miren Garcia-Cortes et al.   ARCHIVES OF TOXICOLOGY

A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury

(2020) Muhammed S Moosa et al.   CLINICAL INFECTIOUS DISEASES

HLA‐B*35:01 and Green Tea Induced Liver Injury

(2020) Jay H. Hoofnagle et al.   HEPATOLOGY

Drug-induced liver injury in older people

(2020) M Isabel Lucena et al.   Lancet Gastroenterology & Hepatology

Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury

(2019) Jawad Ahmad et al.   DIGESTIVE DISEASES AND SCIENCES

Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis

(2019) Arie Regev et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors

(2019) Andrew Stolz et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy

(2019) Irene Tsung et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Next Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development

(2019) Sharin E. Roth et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Development and Validation of Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 months for Patients With Suspected Drug-Induced Liver Injury

(2019) Marwan Ghabril et al.   GASTROENTEROLOGY

Antimicrobials and anti-epileptics are the leading causes of idiosyncratic drug induced liver injury in american children

(2019) Frank DiPaola et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Prednisone is not beneficial for the treatment of severe drug-induced liver injury

(2019) Yue-Meng Wan et al.   MEDICINE

Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug‐induced liver injury from autoimmune hepatitis

(2019) Sabine Weber et al.   LIVER INTERNATIONAL

Drug-induced liver injury

(2019) Raul J. Andrade et al.   Nature Reviews Disease Primers

Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease

(2019) Melissa Palmer et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors

(2019) Ethan D. Miller et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Non‐alcoholic fatty liver disease is a potential risk factor for liver injury caused by immune checkpoint inhibitor

(2019) Koji Sawada et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Diagnostic and prognostic assessment of suspected drug‐induced liver injury in clinical practice

(2019) Raúl J. Andrade et al.   LIVER INTERNATIONAL

International Policy Frameworks for Consent in Minimal-risk Pragmatic Trials

(2019) Tanya J. Symons et al.   ANESTHESIOLOGY

Epidemiology, Predisposing Factors, and Outcomes of Drug-Induced Liver Injury

(2019) Einar S. Björnsson   Clinics in Liver Disease

Severe liver injury due to herbal and dietary supplements and the role of liver transplantation

(2019) Priya Grewal et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers

(2018) Lara Dakhoul et al.   Clinical Gastroenterology and Hepatology

Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry

(2018) Inmaculada Medina-Caliz et al.   Clinical Gastroenterology and Hepatology

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

(2018) Julie R. Brahmer et al.   JOURNAL OF CLINICAL ONCOLOGY

Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents

(2018) Daniel L. Suzman et al.   LIVER INTERNATIONAL

Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view

(2018) Fernando Bessone et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug-Induced Liver Injury

(2018) Craig Lammert et al.   Clinical Gastroenterology and Hepatology

Relevance of CYP2C9 Function in Valproate Therapy

(2018) Katalin Monostory et al.   Current Neuropharmacology

Drug-Induced Liver Injury: Highlights of the Recent Literature

(2018) Mark Real et al.   DRUG SAFETY

Death and liver transplantation within 2 years of onset of drug-induced liver injury

(2017) Paul H. Hayashi et al.   HEPATOLOGY

Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements

(2017) Herbert L. Bonkovsky et al.   HEPATOLOGY

Clinical Spectrum and Outcome of Pediatric Drug Induced Liver Injury

(2017) Aditi Kumar et al.   INDIAN JOURNAL OF PEDIATRICS

The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study

(2016) Abhasnee Sobhonslidsuk et al.   BMC GASTROENTEROLOGY

Ability of King's College Criteria and Model for End-Stage Liver Disease Scores to Predict Mortality of Patients With Acute Liver Failure: A Meta-analysis

(2016) Mark J.W. McPhail et al.   Clinical Gastroenterology and Hepatology

Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure

(2016) David G. Koch et al.   Clinical Gastroenterology and Hepatology

Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series

(2016) Lauren A. Heidemann et al.   DIGESTIVE DISEASES AND SCIENCES

Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C–Related Compensated Cirrhosis

(2016) Arpan Mohanty et al.   GASTROENTEROLOGY

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis

(2016) Juan G. Abraldes et al.   GASTROENTEROLOGY

Liver injury from herbal and dietary supplements

(2016) Victor J. Navarro et al.   HEPATOLOGY

Beneficial effect of corticosteroids for patients with severe drug-induced liver injury

(2016) Ping Fang Hu et al.   Journal of Digestive Diseases

Hepatic decompensation during direct-acting antiviral therapy of chronic hepatitis C

(2016) Jay H. Hoofnagle   JOURNAL OF HEPATOLOGY

Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury

(2016) Inmaculada Medina-Caliz et al.   JOURNAL OF HEPATOLOGY

Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States

(2016) K. Rajender Reddy et al.   LIVER TRANSPLANTATION

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

(2015) Naga Chalasani et al.   GASTROENTEROLOGY

167 Herbal and Dietary Supplement Induced Hepatotoxicity in the U.S.

(2015) Victor J. Navarro et al.   GASTROENTEROLOGY

EASL Clinical Practice Guidelines: Wilson’s disease

(2015)   JOURNAL OF HEPATOLOGY

Hepatitis C in African Americans

(2014) Sammy Saab et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

(2014) Naga P Chalasani et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network

(2014) Mark W. Russo et al.   HEPATOLOGY

Age-related differences in reporting of drug-associated liver injury: Data-mining of WHO Safety Report Database

(2014) Christine M. Hunt et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Review article: prescribing medications in patients with cirrhosis - a practical guide

(2013) J. H. Lewis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Acute Liver Injury due to Flavocoxid (Limbrel), a Medical Food for Osteoarthritis

(2013) Naga Chalasani   ANNALS OF INTERNAL MEDICINE

The Increasing Burden of Mortality From Viral Hepatitis in the United States

(2013) Edward L. Murphy   ANNALS OF INTERNAL MEDICINE

Albumin Dialysis With a Noncell Artificial Liver Support Device in Patients With Acute Liver Failure

(2013) Faouzi Saliba et al.   ANNALS OF INTERNAL MEDICINE

The effect of infections on the mortality of cirrhotic patients with hepatic encephalopathy

(2013) T. H. HUNG et al.   EPIDEMIOLOGY AND INFECTION

Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland

(2013) Einar S. Björnsson et al.   GASTROENTEROLOGY

Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations

(2013) David E. Kleiner et al.   HEPATOLOGY

A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients

(2013) T. Bader et al.   JOURNAL OF VIRAL HEPATITIS

Impact of Geographic Range on Genetic and Chemical Diversity of Indian Valerian (Valeriana jatamansi) from Northwestern Himalaya

(2012) V. Sundaresan et al.   BIOCHEMICAL GENETICS

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: A placebo-controlled clinical trial

(2012) Robert H. Squires et al.   HEPATOLOGY

Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation

(2012) Stepan Sembera et al.   LIVER TRANSPLANTATION

Hepatitis E

(2012) Jay H. Hoofnagle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury

(2011) Alexander Wree et al.   DIGESTION

Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury

(2011) Timothy J. Davern et al.   GASTROENTEROLOGY

The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury

(2011) Ayako Suzuki et al.   HEPATOLOGY

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

(2011) Marc G. Ghany et al.   HEPATOLOGY

Chemical and Genetic Assessment of Variability in Commercial Radix Astragali (Astragalusspp.) by Ion Trap LC−MS and Nuclear Ribosomal DNA Barcoding Sequence Analyses

(2011) Wei-Lie Xiao et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Characteristics of Idiosyncratic Drug-induced Liver Injury in Children

(2011) Jean P. Molleston et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Mechanisms of drug-induced liver injury: from bedside to bench

(2011) Shannan Tujios et al.   Nature Reviews Gastroenterology & Hepatology

Important Elements for the Diagnosis of Drug-Induced Liver Injury

(2010) Vijay K. Agarwal et al.   Clinical Gastroenterology and Hepatology

Risk Factors for Idiosyncratic Drug-Induced Liver Injury

(2010) Naga Chalasani et al.   GASTROENTEROLOGY

Clinical syndromes and consequences of antiretroviral-related hepatotoxicity

(2010) Marina Núñez   HEPATOLOGY

Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop

(2010) Robert J. Fontana et al.   HEPATOLOGY

Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method

(2010) Don C. Rockey et al.   HEPATOLOGY

Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study

(2010) Adrian Reuben et al.   HEPATOLOGY

Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury

(2010) Lars P. Bechmann et al.   JOURNAL OF HEPATOLOGY

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

(2010) Vasilios G Athyros et al.   LANCET

Propylthiouracil use associated with severe hepatotoxicity in children

(2010) Linda Koch   Nature Reviews Endocrinology

Phenolic composition and antioxidant properties of some traditionally used medicinal plants affected by the extraction time and hydrolysis

(2010) Draženka Komes et al.   PHYTOCHEMICAL ANALYSIS

Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure

(2009) William M. Lee et al.   GASTROENTEROLOGY

Burden of Digestive Diseases in the United States Part I: Overall and Upper Gastrointestinal Diseases

(2009) James E. Everhart et al.   GASTROENTEROLOGY

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference

(2009) Robert E. Kalb et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Drug-induced liver injury following positive drug rechallenge

(2009) Julie I. Papay et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ ( POLG1 )

(2008) R McFarland et al.   ARCHIVES OF DISEASE IN CHILDHOOD

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

(2008) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

(2008) Naga Chalasani et al.   GASTROENTEROLOGY

Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury

(2008) James Rochon et al.   HEPATOLOGY

Simplified criteria for the diagnosis of autoimmune hepatitis

(2008) Elke M. Hennes et al.   HEPATOLOGY

Lead, Mercury, and Arsenic in US- and Indian-Manufactured Ayurvedic Medicines Sold via the Internet

(2008) Robert B. Saper   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Severe hepatotoxicity following ingestion of Herbalife® nutritional supplements contaminated with Bacillus subtilis

(2008) Felix Stickel et al.   JOURNAL OF HEPATOLOGY

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal